(EKUS) BNP Paribas Easy MSCI USA - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1659681669 • US Large-Cap Blend Equity

EKUS: Stocks, Bonds, Currencies, Commodities, ETFs

BNP Paribas Easy MSCI USA SRI S-Series PAB 5% Capped UCITS ETF EUR Distribution (XETRA: EKUS) is a European exchange-traded fund designed for investors seeking exposure to US large and mid-cap equities with a focus on sustainability. The fund tracks the Morningstar US Large-Mid NR USD Index, which includes companies that meet specific ESG criteria. This ETF is UCITS-compliant, ensuring adherence to European regulatory standards for investor protection and transparency.

With an AUM of approximately 969.87 million EUR, the fund offers a diversified portfolio of US equities. The ETF employs a capped weighting strategy, ensuring no single issuer exceeds 5% of the funds assets. This approach mitigates concentration risk and aligns with risk management principles often emphasized in institutional investing. The fund distributes income, making it suitable for investors seeking regular income streams alongside capital appreciation.

As an ETF, it provides transparency through daily disclosures of its holdings. Listed on XETRA, it offers European investors easy access to US markets with EUR-denominated shares, reducing currency risk for euro-based investors. The funds expense ratio is competitive within its category, reflecting BNP Paribas Asset Managements focus on cost efficiency. Investors should consider the funds tracking error and the potential impact of ESG screening on sector weights compared to broader market indices.

For fund managers and institutional investors, this ETF serves as a building block for constructing diversified, ESG-focused portfolios. It aligns with the growing demand for sustainable investing while maintaining exposure to the growth potential of US large and mid-cap companies. As with any investment, understanding the underlying index methodology and monitoring the funds sector weights are critical for making informed decisions.

Remember, investing is about the process, not just the outcome. Always do your homework, stay disciplined, and focus on the things that matter most to you and your investors.

Additional Sources for EKUS ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

EKUS ETF Overview

Market Cap in USD 1,047m
Category US Large-Cap Blend Equity
TER 0.25%
IPO / Inception 2017-10-25

EKUS ETF Ratings

Growth 5y 80.8%
Fundamental -
Dividend 54.2%
Rel. Strength -6.59
Analysts -
Fair Price Momentum 19.10 EUR
Fair Price DCF -

EKUS Dividends

Dividend Yield 12m 1.53%
Yield on Cost 5y 3.19%
Annual Growth 5y 8.10%
Payout Consistency 95.6%

EKUS Growth Ratios

Growth Correlation 3m -70.4%
Growth Correlation 12m 76.7%
Growth Correlation 5y 89.6%
CAGR 5y 15.55%
CAGR/Max DD 5y 0.73
Sharpe Ratio 12m 1.12
Alpha -6.74
Beta 1.070
Volatility 19.57%
Current Volume 3.9k
Average Volume 20d 4.2k
What is the price of EKUS stocks?
As of April 03, 2025, the stock is trading at EUR 20.23 with a total of 3,894 shares traded.
Over the past week, the price has changed by -1.39%, over one month by -7.14%, over three months by -8.17% and over the past year by +2.92%.
Is BNP Paribas Easy MSCI USA a good stock to buy?
Yes. Based on ValueRay Analyses, BNP Paribas Easy MSCI USA (XETRA:EKUS) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 80.84 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EKUS as of April 2025 is 19.10. This means that EKUS is currently overvalued and has a potential downside of -5.59%.
Is EKUS a buy, sell or hold?
BNP Paribas Easy MSCI USA has no consensus analysts rating.
What are the forecast for EKUS stock price target?
According to ValueRays Forecast Model, EKUS BNP Paribas Easy MSCI USA will be worth about 21.7 in April 2026. The stock is currently trading at 20.23. This means that the stock has a potential upside of +7.32%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 21.7 7.3%